{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:16:20Z","timestamp":1794755780752,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Musculoskeletal diseases such as osteoarthritis (OA) are leading causes of pain, physical inactivity and disability worldwide. Synovial fibroblasts (SFs) expressing fibroblast activation protein (FAP) are crucial for OA progression. Positron emission tomography (PET) with\n                      <jats:sup>68<\/jats:sup>\n                      Gallium-labelled FAP-inhibitors (\n                      <jats:sup>68<\/jats:sup>\n                      \u00a0Ga-FAPI) visualizes FAP-positive activated fibroblasts. Here, we systematically analyze FAPI-uptake respecting OA and joint degeneration in a cohort of 268 patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      \u00a0Ga-FAPI-PET-scans of 268 oncological patients were analyzed for increased joint-associated FAPI-uptake, quantified by maximal, mean standardized uptake values (SUVmax\/mean) and target to blood ratios (TBR) and compared with computed tomography-based OA-classification according to Kellgren and Lawrence. FAP-expression of SF from OA and rheumatoid arthritis (RA) (15 OA- and 26 RA-patients) were analyzed by single-cell cytometry by time of flight (cyTOF).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      148 of 268 patients (55.2%) showed increased joint-associated FAPI-uptake (average SUVmax\/mean of 3.25\u2009\u00b1\u20091.28\/ 1.94\u2009\u00b1\u20090.70). The most frequent FAPI-positive joints were acromioclavicular and shoulder joints followed by sternoclavicular, lumbar facet and hip joints. FAPI-uptake was frequently asymmetric whereas OA-scoring displayed a symmetric allocation of degenerative changes suggesting discordance between FAPI-uptake and OA-scoring. Only in end-stage-OA (grade 4 according to Kellgren and Lawrence) FAPI-uptake was concordantly and significantly elevated. Abundant FAP-positive fibroblasts in end-stage-OA were confirmed by CyTOF\n                      <jats:bold>.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FAPI-uptake in joints is frequent and can occur in presence as well as in absence of joint degeneration. We suggest that FAPI-PET\/CT complements conventional musculoskeletal imaging by providing information on synovial activity, the exact triggers of which remain to be elucidated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-025-07636-x","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:11:20Z","timestamp":1763608280000},"page":"3226-3237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["68Gallium-labelled fibroblast activation protein inhibitor uptake in joints: a single-center cohort analysis of 268 patients"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1092-5773","authenticated-orcid":false,"given":"Anna-Maria","family":"Spektor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"van Genabith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hoppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Walkenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hielscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kvacskay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiangenda Tr\u00e9sor","family":"Sungu-Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Kauczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Martin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-154X","authenticated-orcid":false,"given":"Wolfgang","family":"Merkt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"R\u00f6hrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"7636_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020;104:293\u2013311. https:\/\/doi.org\/10.1016\/j.mcna.2019.10.007.","journal-title":"Med Clin North Am"},{"key":"7636_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.joca.2020.10.005","volume":"29","author":"JL Whittaker","year":"2021","unstructured":"Whittaker JL, Truong LK, Dhiman K, Beck C. Osteoarthritis year in review 2020: rehabilitation and outcomes. Osteoarthritis Cartilage. 2021;29:190\u2013207. https:\/\/doi.org\/10.1016\/j.joca.2020.10.005.","journal-title":"Osteoarthritis Cartilage"},{"key":"7636_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.rdc.2014.07.012","volume":"40","author":"DT Felson","year":"2014","unstructured":"Felson DT, Hodgson R. Identifying and treating preclinical and early osteoarthritis. Rheum Dis Clin North Am. 2014;40:699\u2013710. https:\/\/doi.org\/10.1016\/j.rdc.2014.07.012.","journal-title":"Rheum Dis Clin North Am"},{"key":"7636_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.rdc.2012.10.007","volume":"39","author":"A Abhishek","year":"2013","unstructured":"Abhishek A, Doherty M. Diagnosis and clinical presentation of osteoarthritis. Rheum Dis Clin North Am. 2013;39:45\u201366. https:\/\/doi.org\/10.1016\/j.rdc.2012.10.007.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"7636_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American college of rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220\u201333. https:\/\/doi.org\/10.1002\/art.41142.","journal-title":"Arthritis Rheumatol"},{"key":"7636_CR6","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/rheumatology\/kev228","volume":"54","author":"DF Remst","year":"2015","unstructured":"Remst DF, Blaney Davidson EN, van der Kraan PM. Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness. Rheumatology (Oxford). 2015;54:1954\u201363. https:\/\/doi.org\/10.1093\/rheumatology\/kev228.","journal-title":"Rheumatology (Oxford)"},{"key":"7636_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kew389","volume":"56","author":"T Hugle","year":"2017","unstructured":"Hugle T, Geurts J. What drives osteoarthritis?-synovial versus subchondral bone pathology. Rheumatology (Oxford). 2017;56:1461\u201371. https:\/\/doi.org\/10.1093\/rheumatology\/kew389.","journal-title":"Rheumatology (Oxford)"},{"key":"7636_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/life11010003","author":"YA Rim","year":"2020","unstructured":"Rim YA, Ju JH. The role of fibrosis in osteoarthritis progression. Life. 2020. https:\/\/doi.org\/10.3390\/life11010003.","journal-title":"Life"},{"key":"7636_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307338","volume":"11","author":"B Liu","year":"2024","unstructured":"Liu B, Xian Y, Chen X, Shi Y, Dong J, Yang L, et al. Inflammatory fibroblast-like synoviocyte-derived exosomes aggravate osteoarthritis via enhancing macrophage glycolysis. Adv Sci. 2024;11:e2307338. https:\/\/doi.org\/10.1002\/advs.202307338.","journal-title":"Adv Sci"},{"key":"7636_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1056\/NEJMcibr2024718","volume":"383","author":"CQ Chu","year":"2020","unstructured":"Chu CQ. Fibroblasts in rheumatoid arthritis. N Engl J Med. 2020;383:1679\u201381. https:\/\/doi.org\/10.1056\/NEJMcibr2024718.","journal-title":"N Engl J Med"},{"key":"7636_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233\u201355. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00859.x.","journal-title":"Immunol Rev"},{"key":"7636_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/art.41958","volume":"74","author":"S Zhao","year":"2022","unstructured":"Zhao S, Grieshaber-Bouyer R, Rao DA, Kolb P, Chen H, Andreeva I, et al. Effect of JAK inhibition on the induction of proinflammatory HLA\u2013DR+CD90+ rheumatoid arthritis synovial fibroblasts by interferon-\u03b3. Arthritis Rheumatol. 2022;74:441\u201352. https:\/\/doi.org\/10.1002\/art.41958.","journal-title":"Arthritis Rheumatol"},{"key":"7636_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928\u201342. https:\/\/doi.org\/10.1038\/s41590-019-0378-1.","journal-title":"Nat Immunol"},{"key":"7636_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/ard.2006.067470","volume":"66","author":"CL Hill","year":"2007","unstructured":"Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis. 2007;66:1599\u2013603. https:\/\/doi.org\/10.1136\/ard.2006.067470.","journal-title":"Ann Rheum Dis"},{"key":"7636_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1486-7","volume":"19","author":"A Sarmanova","year":"2017","unstructured":"Sarmanova A, Hall M, Fernandes GS, Bhattacharya A, Valdes AM, Walsh DA, et al. Association between ultrasound-detected synovitis and knee pain: a population-based case\u2013control study with both cross-sectional and follow-up data. Arthritis Res Ther. 2017;19:281. https:\/\/doi.org\/10.1186\/s13075-017-1486-7.","journal-title":"Arthritis Res Ther"},{"key":"7636_CR16","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1007\/s11999-016-4732-4","volume":"474","author":"MD Kohn","year":"2016","unstructured":"Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474:1886\u201393. https:\/\/doi.org\/10.1007\/s11999-016-4732-4.","journal-title":"Clin Orthop Relat Res"},{"key":"7636_CR17","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.joca.2014.04.030","volume":"22","author":"M Siebelt","year":"2014","unstructured":"Siebelt M, Agricola R, Weinans H, Kim YJ. The role of imaging in early hip OA. Osteoarthritis Cartilage. 2014;22:1470\u201380. https:\/\/doi.org\/10.1016\/j.joca.2014.04.030.","journal-title":"Osteoarthritis Cartilage"},{"key":"7636_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587:555\u201366. https:\/\/doi.org\/10.1038\/s41586-020-2938-9.","journal-title":"Nature"},{"issue":"6","key":"7636_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"7636_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semcdb.2019.12.006","volume":"101","author":"T Pap","year":"2020","unstructured":"Pap T, Dankbar B, Wehmeyer C, Korb-Pap A, Sherwood J. Synovial fibroblasts and articular tissue remodelling: role and mechanisms. Semin Cell Dev Biol. 2020;101:140\u20135. https:\/\/doi.org\/10.1016\/j.semcdb.2019.12.006.","journal-title":"Semin Cell Dev Biol"},{"key":"7636_CR21","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220463","volume":"96","author":"M Hotta","year":"2023","unstructured":"Hotta M, Rieger AC, Jafarvand MG, Menon N, Farolfi A, Benz MR, et al. Non-oncologic incidental uptake on FAPI PET\/CT imaging. Br J Radiol. 2023;96:20220463. https:\/\/doi.org\/10.1259\/bjr.20220463.","journal-title":"Br J Radiol"},{"key":"7636_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae225","author":"M R\u00f6hrich","year":"2024","unstructured":"R\u00f6hrich M, Rosales JJ, Hoppner J, Kvacskay P, Blank N, Loi L, et al. Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission. Rheumatology (Oxford). 2024. https:\/\/doi.org\/10.1093\/rheumatology\/keae225.","journal-title":"Rheumatology (Oxford)"},{"key":"7636_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M R\u00f6hrich","year":"2021","unstructured":"R\u00f6hrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, et al. Impact of (68)Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med. 2021;62:779\u201386. https:\/\/doi.org\/10.2967\/jnumed.120.253062.","journal-title":"J Nucl Med"},{"key":"7636_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.121.261925","volume":"63","author":"M Rohrich","year":"2022","unstructured":"Rohrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, et al. Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med. 2022;63:127\u201333. https:\/\/doi.org\/10.2967\/jnumed.121.261925.","journal-title":"J Nucl Med"},{"key":"7636_CR25","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.2967\/jnumed.123.266046","volume":"64","author":"SA Koerber","year":"2023","unstructured":"Koerber SA, R\u00f6hrich M, Walkenbach L, Liermann J, Choyke PL, Fink C, et al. Impact of (68)Ga-FAPI PET\/CT on staging and oncologic management in a cohort of 226 patients with various cancers. J Nucl Med. 2023;64:1712\u201320. https:\/\/doi.org\/10.2967\/jnumed.123.266046.","journal-title":"J Nucl Med"},{"key":"7636_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2967\/jnumed.123.266393","volume":"65","author":"AM Spektor","year":"2024","unstructured":"Spektor AM, Gutjahr E, Lang M, Glatting FM, Hackert T, Pausch T, et al. Immunohistochemical FAP expression reflects (68)Ga-FAPI PET imaging properties of low- and high-grade intraductal papillary mucinous neoplasms and pancreatic ductal adenocarcinoma. J Nucl Med. 2024;65:52\u20138. https:\/\/doi.org\/10.2967\/jnumed.123.266393.","journal-title":"J Nucl Med"},{"key":"7636_CR27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222052","volume":"307","author":"Y Luo","year":"2023","unstructured":"Luo Y, Pan Q, Zhou Z, Li M, Wei Y, Jiang X, et al. (68)Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study. Radiology. 2023;307:e222052. https:\/\/doi.org\/10.1148\/radiol.222052.","journal-title":"Radiology"},{"key":"7636_CR28","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s12149-021-01673-w","volume":"35","author":"S Zheng","year":"2021","unstructured":"Zheng S, Lin R, Chen S, Zheng J, Lin Z, Zhang Y, et al. Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET\/CT. Ann Nucl Med. 2021;35:1312\u201320. https:\/\/doi.org\/10.1007\/s12149-021-01673-w.","journal-title":"Ann Nucl Med"},{"key":"7636_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/rlu.0000000000004213","volume":"47","author":"W Gong","year":"2022","unstructured":"Gong W, Chen S, He L, Liu W, Zhang C. Intense 68Ga-FAPI uptake in a patient with myositis ossificans: mimicking bone malignancy. Clin Nucl Med. 2022;47:638\u20139. https:\/\/doi.org\/10.1097\/rlu.0000000000004213.","journal-title":"Clin Nucl Med"},{"key":"7636_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/rlu.0000000000003671","volume":"46","author":"Y Song","year":"2021","unstructured":"Song Y, Qin C, Liu F, Lan X. Fibrous dysplasia mimicking skeletal metastasis on 68Ga-FAPI PET imaging. Clin Nucl Med. 2021;46:774\u20135. https:\/\/doi.org\/10.1097\/rlu.0000000000003671.","journal-title":"Clin Nucl Med"},{"key":"7636_CR31","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/rheumatology\/keab664","volume":"61","author":"DN Dorst","year":"2022","unstructured":"Dorst DN, Rijpkema M, Buitinga M, Walgreen B, Helsen MMA, Brennan E, et al. Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy. Rheumatology (Oxford). 2022;61:2999\u20133009. https:\/\/doi.org\/10.1093\/rheumatology\/keab664.","journal-title":"Rheumatology (Oxford)"},{"key":"7636_CR32","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1007\/s00259-022-05836-3","volume":"49","author":"L Ge","year":"2022","unstructured":"Ge L, Fu Z, Wei Y, Shi D, Geng Y, Fan H, et al. Preclinical evaluation and pilot clinical study of [(18)F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis. Eur J Nucl Med Mol Imaging. 2022;49:4025\u201336. https:\/\/doi.org\/10.1007\/s00259-022-05836-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7636_CR33","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1097\/rlu.0000000000003854","volume":"47","author":"\u00d6 Erol Fenercio\u011flu","year":"2022","unstructured":"Erol Fenercio\u011flu \u00d6, Beyhan E, Erg\u00fcl N, Arslan E, \u00c7ermik TF. 18F-FDG PET\/CT and 68Ga-FAPI-4 PET\/CT findings of bilateral knee osteoarthritis in a patient with uveal malignant melanoma. Clin Nucl Med. 2022;47:e144\u20136. https:\/\/doi.org\/10.1097\/rlu.0000000000003854.","journal-title":"Clin Nucl Med"},{"key":"7636_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/rlu.0000000000003957","volume":"47","author":"X Yang","year":"2022","unstructured":"Yang X, You Z, Gong W, Chen Y, Liu H. Increased 68Ga-FAPI uptake in facet joint osteoarthritis in a patient with esophageal cancer. Clin Nucl Med. 2022;47:342\u20133. https:\/\/doi.org\/10.1097\/rlu.0000000000003957.","journal-title":"Clin Nucl Med"},{"key":"7636_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154514","volume":"11","author":"F Dondi","year":"2022","unstructured":"Dondi F, Albano D, Treglia G, Bertagna F. Emerging role of FAPI PET imaging for the assessment of benign bone and joint diseases. J Clin Med. 2022;11:4514.","journal-title":"J Clin Med"},{"key":"7636_CR36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"key":"7636_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-021-00144-x","volume":"6","author":"T Lindner","year":"2021","unstructured":"Lindner T, Altmann A, Giesel F, Kratochwil C, Kleist C, Kr\u00e4mer S, et al. (18)F-labeled tracers targeting fibroblast activation protein. EJNMMI Radiopharm Chem. 2021;6:26. https:\/\/doi.org\/10.1186\/s41181-021-00144-x.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"7636_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jager D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"key":"7636_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135384","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N, et al. Role and mechanism of fibroblast-activated protein-\u03b1 expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front Immunol. 2023;14:1135384. https:\/\/doi.org\/10.3389\/fimmu.2023.1135384.","journal-title":"Front Immunol"},{"key":"7636_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.183690","author":"J Miyahara","year":"2025","unstructured":"Miyahara J, Omata Y, Chijimatsu R, Okada H, Ishikura H, Higuchi J, et al. CD34hi subset of synovial fibroblasts contributes to fibrotic phenotype of human knee osteoarthritis. JCI Insight. 2025. https:\/\/doi.org\/10.1172\/jci.insight.183690.","journal-title":"JCI Insight"},{"key":"7636_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11307-023-01817-6","volume":"25","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Lin X, Wang W, Zhang X, L\u00fc M, Shao Z, et al. Evaluation of (18)F-FAPI-04 imaging in assessing the therapeutic response of rheumatoid arthritis. Mol Imaging Biol. 2023;25:630\u20137. https:\/\/doi.org\/10.1007\/s11307-023-01817-6.","journal-title":"Mol Imaging Biol"},{"key":"7636_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12149-023-01896-z","volume":"38","author":"SB Singh","year":"2024","unstructured":"Singh SB, Bhandari S, Bhandari S, Bhandari S, Singh R, Raynor WY, et al. Role of PET\/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review. Ann Nucl Med. 2024;38:165\u201375. https:\/\/doi.org\/10.1007\/s12149-023-01896-z.","journal-title":"Ann Nucl Med"},{"key":"7636_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11307-023-01893-8","volume":"26","author":"Y Matsusaka","year":"2024","unstructured":"Matsusaka Y, Werner RA, Serfling SE, Buck AK, Kosmala A, Sasaki T, et al. Evaluating the patterns of FAPI uptake in the shoulder joint: a preliminary study comparing with FDG uptake in oncological studies. Mol Imaging Biol. 2024;26:294\u2013300. https:\/\/doi.org\/10.1007\/s11307-023-01893-8.","journal-title":"Mol Imaging Biol"},{"key":"7636_CR44","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/s2665-9913(20)30421-5","volume":"3","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, Distler JHW, Treutlein C, Tascilar K, M\u00fcller AT, Atzinger A, et al. (68)Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. Lancet Rheumatol. 2021;3:e185\u201394. https:\/\/doi.org\/10.1016\/s2665-9913(20)30421-5.","journal-title":"Lancet Rheumatol"},{"key":"7636_CR45","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","volume":"45","author":"R Slart","year":"2018","unstructured":"Slart R. FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET interest group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250\u201369. https:\/\/doi.org\/10.1007\/s00259-018-3973-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7636_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.846300","author":"C-Q Chu","year":"2022","unstructured":"Chu C-Q. Highlights of strategies targeting fibroblasts for novel therapies for rheumatoid arthritis. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.846300.","journal-title":"Front Med"},{"key":"7636_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430\u20133. https:\/\/doi.org\/10.1038\/s41586-019-1546-z.","journal-title":"Nature"},{"key":"7636_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/ard-2022-223227","volume":"82","author":"H Swahn","year":"2023","unstructured":"Swahn H, Li K, Duffy T, Olmer M, D\u2019Lima DD, Mondala TS, et al. Senescent cell population with ZEB1 transcription factor as its main regulator promotes osteoarthritis in cartilage and meniscus. Ann Rheum Dis. 2023;82:403\u201315. https:\/\/doi.org\/10.1136\/ard-2022-223227.","journal-title":"Ann Rheum Dis"},{"key":"7636_CR49","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10067-025-07414-y","volume":"44","author":"D Yang","year":"2025","unstructured":"Yang D, Chen J, He G, Zhou Z, Xu J, Peng Y, et al. Comparisons of [(68) Ga]Ga-FAPI-04 PET\/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis. Clin Rheumatol. 2025;44:2191\u20139. https:\/\/doi.org\/10.1007\/s10067-025-07414-y.","journal-title":"Clin Rheumatol"},{"key":"7636_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07310-2","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yu L, Chen S, Liu W, Han H, Pang Y, et al. Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI-46 for evaluation of structural damage and inflammation in axial spondyloarthritis: a prospective study. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07310-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7636_CR51","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2967\/jnumed.122.264069","volume":"63","author":"FM Glatting","year":"2022","unstructured":"Glatting FM, Hoppner J, Liew DP, van Genabith A, Spektor AM, Steinbach L, et al. Repetitive early (68)Ga-FAPI PET acquisition comparing (68)Ga-FAPI-02, (68)Ga-FAPI-46, and (68)Ga-FAPI-74: methodologic and diagnostic implications for malignant, inflammatory\/reactive, and degenerative lesions. J Nucl Med. 2022;63:1844\u201351. https:\/\/doi.org\/10.2967\/jnumed.122.264069.","journal-title":"J Nucl Med"},{"issue":"2","key":"7636_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","volume":"62","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Adeberg S, Syed M, Lindner T, Jim\u00e9nez-Franco LD, Mavriopoulou E, et al. FAPI-74 PET\/CT using either (18)F-AlF or cold-kit (68)Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients. J Nucl Med. 2021;62(2):201\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.245084.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07636-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:26:30Z","timestamp":1774401990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7636"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07636-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective study was approved by the local institutional review board (study number S-115\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a0\n                      \n                      B and\n                      \n                      B.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"UH has filed a patent application for quinoline based FAP targeting agents for imaging and therapy in nuclear medicine. UH also has shares of a consultancy group for iTheranostics. No other relevant conflicts of interest exist.WM has received grants or contracts from ArgenX, Kyverna, Lilly, Galapagos, Boehringer-Ingelheim, Evotec, BMS; consulting fees and payment or honoraria for lectures and presentations from Lilly, Galapagos, Boehringer-Ingelheim; Support for attending meetings and\/or travel Kyverna, Lilly, Galapagos, Boehringer-Ingelheim; Patents planned Evotec, BMS; Participation on an Advisory Board: Lilly, Boehringer-Ingelheim; Receipt of equipment, materials, drugs: ArgenX.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}